j****u
发帖数: 1413 | 1 2015年8月22日，波士顿科大校友会将举办首次医药行业的校友沙龙聚会。我们邀请到
了波士顿医药界三位资深校友陈寅(808)，金晓玮(843) 和李劲波(863)为我们做嘉宾演
讲，纵论中美医药行业发展的机遇和挑战并分享作为科大校友在医药行业发展的心得体
会。欢迎中国科大校友参加，一同欢聚在查尔斯河河畔！
通知网址：http://ustcbaa.com/events/%E6%B3%A2%E5%A3%AB%E9%A1%BF%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%A4%A7%E6%A0%A1%E5%8F%8B%E6%91%86%E4%B8%8B%E9%BE%99%E9%97%A8%E9%98%B5%E5%A4%A7%E8%AF%9D%E5%8C%BB%E8%8D%AF%E5%88%9B%E6%96%B0%E9%A2%86%E5%9F%9F/
时间： 2015年8月22日14:00-16：00
地点：220 Longwood Ave, Boston, MA。 教室 Goldenson 122, Harvard Medical
School(周围停车较不便, 可乘坐绿线E, Longwood站下车), 找不到教室或者进入不了
大门，请联系(0219)白莎， 电话：3025626516
报名方式: http://goo.gl/forms/zpc57lpL8K
演讲嘉宾：
陈寅（808）Director of Business Development at Accelagen, Founder/President/
CEO at MTT Pharmaceuticals
金晓玮（843）Director，Biology at Hua Medicine
李劲波(863) Chief Scientific Officer at Scilligence Corp
演讲嘉宾简介
陈寅（808）
Dr. Yin Chen is a biotech entrepreneur with over 15 experiences in the
industry. After serving as Chief Scientific Officer in a biotech company for
9 years, he co-foundered and became President/CEO of MTT Pharmaceuticals in
2008. Dr. Chen is currently consulting for several US and international
pharmaceutical companies for product marketing, business development and
fund raising.
Dr. Chen received his Bachelor of Science degree from University of Science
& Technology China, Master of Science degree from Shanghai Institute of
Biochemistry and Ph.D degree from University of Maine. He subsequently
completed his postdoc training at Beth Israel Deaconess Medical Center/
Harvard Medical School. In 2013, Dr. Chen earned his EMBA from Jack Welch
Management Institute.
金晓玮（843）
Dr. Xiaowei Jin has over 12 years’ experience in the biotechnology and
pharmaceutical industry. She was formerly Vice President of Discovery
Biology at Medicilon. She worked in the areas of CNS disorders, inflammation
, metabolic and cardiovascular diseases. Prior to returning to China from
the US, she was Team Leader for the Neurodegenerative Disease Focus Area of
CombinatoRx (now Zalicus). Prior to this, Dr. Jin was a research scientist
in the Pharmacology Department at Biogen (now Biogen Idec), focusing on
small molecules against Parkinson Disease.
Dr. Jin received her PhD in Biochemistry and Pharmacology from the
University of Virginia and completed her postdoctoral training at Harvard
Medical School. She obtained her BS from the University of Science &
Technology of China with highest honors. Dr. Jin is the author of more than
20 publications in journals such as Cell, Neuron, Nature Biotech., JCI,
Molecular Pharmacology, and has several national and international patents.
李劲波(863)
Co-founder and CSO, Scilligence Corporation
Dr. Jinbo Lee is the co-founder and Chief Scientific Officer of Scilligence
Corporation. He has extensive experience in drug discovery and development
in both pharmaceutical and biotech companies with senior leadership
positions. Most recently as the Head of Chemistry at Ensemble Therapeutics,
he was responsible for molecule modeling/cheminformatics, medicinal
chemistry, process chemistry, and analytical chemistry. Prior to Ensemble
Therapeutics, Dr. Lee led multi-discipline teams at Wyeth Pharmaceuticals.
He has also worked at Boehringer Ingelheim Pharmaceuticals in the areas of
medicinal chemistry, combinatorial chemistry and parallel synthesis. Dr. Lee
has in-depth knowledge in multiple diseases areas including oncology,
metabolic diseases, neurodegenerative diseases, infectious diseases, and
inflammatory and autoimmune diseases. He is an expert in research
informatics, medicinal chemistry, structure-based drug design and prodrug
design. Dr. Lee received his Ph.D. degree in Organic Chemistry from
Princeton University. He was the year 1997 recipient of Roche Award for
Excellence in Organic Chemistry. Dr. Lee has many publications in
prestigious scientific journals and holds a number of patent/patent
applications. He has been an invited speaker in numerous drug discovery and
scientific conferences. |
|
